Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial

Abstract

Our data suggest that Seme administration in pharmacological doses for a period of 6 months seems to have no significant effect on serum thyroid auto-antibodies' levels or lymphocyte infiltration of the thyroid gland.